eClinical Solutions Market worth USD 16.36 billion by 2027 - Exclusive Report by Precedence Research

 The global eClinical Solutions Market is projected to reach US$ 16.36 billion by the end of the year 2027, and growing at a CAGR of 13.6% from 2020 to 2027.

The latest study collated and published by Precedence Research analyzes the historical and present-day scenario of the global eClinical Solutions market in order to accurately gauge its future growth. The study presents detailed information about the important growth factors, restraints, and trends that are creating a landscape for the growth of the global eClinical Solutions market so as to identify growth opportunities for market stakeholders. The report also provides insightful information about how the global eClinical Solutions market would expand during the forecast period of 2020 to 2027.

Get the Sample Pages of Report@ https://www.precedenceresearch.com/sample/1092

The report offers intricate dynamics about different aspects of the global eClinical Solutions market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global eClinical Solutions market during the forecast period. It also includes a key indicator assessment that highlights growth prospects of the global eClinical Solutions market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).

This study covers a detailed segmentation of the global eClinical Solutions market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global eClinical Solutions market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.

Market Segmentation

By Product

• EDC & CDMS
• eCOA
• Clinical Data Integration Platforms
• CTMS
• Safety Solutions
• RTSM
• Clinical Analytics platforms
• eTMF

By Development Phase

• Phase IV
• Phase III
• Phase II
• Phase I

By Delivery Mode

• Licensed Enterprise
• Web-hosted
• Cloud-based

By End-Use

• CROs
• Hospitals
• Academic Institutes
• Medical Device Manufacturers
• Pharma & Biotech Organizations

By Regional Outlook

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • France
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• Rest of the World

Key Players

• PAREXEL International
• Oracle Corp.
• Bioclinica
• Medidata Solution
• DATATRAK
• ERT Clinical
• CRF Health
• eClinicalWorks
• OmniComm Systems
• IBM Watson Health
• eClinical Solutions

Get Customization on this Research Report@ https://www.precedenceresearch.com/customization/1092

Research Methodology

The research methodology adopted by analysts for compiling the global eClinical Solutions market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global eClinical Solutions market.

Table of Content

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global eClinical Solutions Market, By Product

7.1. eClinical Solutions Market, by Product Type, 2020-2027
7.1.1. EDC & CDMS
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. eCOA
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Clinical Data Integration Platforms
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. CTMS
7.1.4.1. Market Revenue and Forecast (2016-2027)
7.1.5. Safety Solutions
7.1.5.1. Market Revenue and Forecast (2016-2027)
7.1.6. RTSM
7.1.6.1. Market Revenue and Forecast (2016-2027)
7.1.7. Clinical Analytics platforms
7.1.7.1. Market Revenue and Forecast (2016-2027)
7.1.8. eTMF
7.1.8.1. Market Revenue and Forecast (2016-2027)

Chapter 8. Global eClinical Solutions Market, By Development Phase

8.1. eClinical Solutions Market, by Development Phase, 2020-2027
8.1.1. Phase IV
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Phase III
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Phase II
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Phase I
8.1.4.1. Market Revenue and Forecast (2016-2027)

Chapter 9. Global eClinical Solutions Market, By Delivery Mode

9.1. eClinical Solutions Market, by Delivery Mode, 2020-2027
9.1.1. Licensed Enterprise
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Web-hosted
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Cloud-based
9.1.3.1. Market Revenue and Forecast (2016-2027)

Chapter 10. Global eClinical Solutions Market, By End-Use

10.1. eClinical Solutions Market, by End-Use, 2020-2027
10.1.1. CROs
10.1.1.1. Market Revenue and Forecast (2016-2027)
10.1.2. Hospitals
10.1.2.1. Market Revenue and Forecast (2016-2027)
10.1.3. Academic Institutes
10.1.3.1. Market Revenue and Forecast (2016-2027)
10.1.4. Medical Device Manufacturers
10.1.4.1. Market Revenue and Forecast (2016-2027)
10.1.5. Pharma & Biotech Organizations
10.1.5.1. Market Revenue and Forecast (2016-2027)

Chapter 11. Global eClinical Solutions Market, Regional Estimates and Trend Forecast

11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2016-2027)
11.1.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.1.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.1.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Product (2016-2027)
11.1.5.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.1.5.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.1.5.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Product (2016-2027)
11.1.6.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.1.6.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.1.6.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2016-2027)
11.2.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.2.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.2.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Product (2016-2027)
11.2.5.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.2.5.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.2.5.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Product (2016-2027)
11.2.6.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.2.6.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.2.6.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Product (2016-2027)
11.2.7.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.2.7.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.2.7.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Product (2016-2027)
11.2.8.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.2.8.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.2.8.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2016-2027)
11.3.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.3.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.3.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Product (2016-2027)
11.3.5.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.3.5.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.3.5.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Product (2016-2027)
11.3.6.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.3.6.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.3.6.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Product (2016-2027)
11.3.7.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.3.7.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.3.7.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Product (2016-2027)
11.3.8.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.3.8.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.3.8.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2016-2027)
11.4.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.4.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.4.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Product (2016-2027)
11.4.5.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.4.5.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.4.5.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Product (2016-2027)
11.4.6.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.4.6.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.4.6.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Product (2016-2027)
11.4.7.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.4.7.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.4.7.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Product (2016-2027)
11.4.8.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.4.8.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.4.8.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2016-2027)
11.5.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.5.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.5.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Product (2016-2027)
11.5.5.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.5.5.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.5.5.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Product (2016-2027)
11.5.6.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.5.6.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.5.6.4. Market Revenue and Forecast, by End-Use (2016-2027)

Chapter 12. Company Profiles

12.1. PAREXEL International
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Oracle Corp.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Bioclinica
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Medidata Solution
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. DATATRAK
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. ERT Clinical
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. CRF Health
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. eClinicalWorks
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. OmniComm Systems
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. IBM Watson Health
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
12.11. eClinical Solutions
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance
12.11.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions

Chapter 14. Appendix

14.1. About Us
14.2. Glossary of Terms

Complete Payment Process and Get Full Access of this Research Report@ https://www.precedenceresearch.com/checkout/1092

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

Blog: https://precedenceresearchnews.wordpress.com

Follow us on LinkedIn | Twitter | Facebook